Last Updated : August 25, 2022
Details
FilesGeneric Name:
ripretinib
Project Status:
Complete
Therapeutic Area:
Gastrointestinal stromal tumours
Manufacturer:
Medison Pharma Canada Inc.
Brand Name:
Qinlock
Project Line:
Reimbursement Review
Project Number:
PC0265-000
Tumour Type:
Gastrointestinal
NOC Status at Filing:
Post NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib.
Fee Schedule:
Schedule A
Indications:
For the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
Key Milestones2 | |
|---|---|
| Call for patient/clinician input open | 16-Sep-21 |
| Call for patient/clinician input closed | 05-Nov-21 |
| Clarification: - Patient input submission received from CanCertainty and GIST Sarcoma Life Raft Group Canada (LRGC) | |
| Submission received | 15-Oct-21 |
| Submission accepted | 29-Oct-21 |
| Review initiated | 01-Nov-21 |
| Draft CADTH review report(s) provided to sponsor for comment | 20-Jan-22 |
| Deadline for sponsors comments | 31-Jan-22 |
| CADTH review report(s) and responses to comments provided to sponsor | 25-Feb-22 |
| Expert committee meeting (initial) | 09-Mar-22 |
| Draft recommendation issued to sponsor | 22-Mar-22 |
| Draft recommendation posted for stakeholder feedback | 31-Mar-22 |
| End of feedback period | 14-Apr-22 |
| Final recommendation issued to sponsor and drug plans | 28-Apr-22 |
| Final recommendation posted | 16-May-22 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 12-May-22 |
| CADTH review report(s) posted | 25-Aug-22 |
Files
Last Updated : August 25, 2022